using polytetrafluoroethylene (PTFE) interposition grafts published in the past 10 years.
Methods: We conducted a single-center retrospective review of all patients who have undergone surgical resection of IVC leiomyosarcomas since January 1, 2007. Information about the procedure and patientspecific data were obtained from the institution's electronic medical record.
Results: We identified five patients (four women, one man) who had undergone surgical resection for IVC leiomyosarcoma. Final pathologic findings were consistent with primary moderate-to high-grade leiomyosarcoma of the IVC in all five cases. Four patients were reconstructed with PTFE interposition grafts (Fig 2) , whereas one patient was repaired using a bovine pericardial patch. There was no perioperative mortality within our population of patients. One patient returned within 30 days with an acute kidney injury associated with a partially occlusive thrombus in the proximal part of the PTFE conduit. Two patients developed distant metastases within a year of surgery, despite having tumor-free margins at the time of the initial operation. All of the PTFE interposition grafts remained patent throughout follow-up without need for additional intervention.
Conclusions: PTFE is a safe and effective conduit as an interposition graft for caval reconstruction after resection of a primary leiomyosarcoma of the IVC.
Author Disclosures: M. K. Eskandari: Nothing to disclose; A. K. Jain: Nothing to disclose; A. Kalluri: Nothing to disclose; H. Rodriguez: Nothing to disclose. Objective: There is still significant controversy and debate about the order and manner by which patients with significant chronic venous insufficiency with combination of iliocaval obstruction reflected by significant common femoral vein (CFV) reflux time associated with severe reflux disease of the great saphenous vein (GSV) should be treated. The aim of this study was to assess whether treatment of iliocaval disease alone can alleviate Venous Clinical Severity Score (VCSS) and minimize the need to ablate the GSV.
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Treatment of Iliocaval Obstruction
Methods: This study was a retrospective review of a single cohort of patients with chronic venous insufficiency and severe reflux disease. Patients with chronic venous disorders and a comprehensive classification system (Clinical, Etiology, Anatomy, and Pathophysiology) class of 3 or 4 were included. The cohort of patients underwent iliocaval interrogation with venography and intravascular ultrasound followed by angioplasty and stenting for venous outflow obstruction. The data were collected during a 10-year period. The primary end point of the study was change in VCSS, defined as the difference in VCSS before and after intervention.
Results: A total of 66 limbs in 45 patients were analyzed. Demographics gathered at the time of initial clinic visit resulted in an average age of 62.4 6 9.9 years and body mass index 35.4 6 12.6 kg/ m 2 . The majority of the treated limbs were for women (n ¼ 53 [80.3%]) as opposed to men (n ¼ 13 [19.7%]). The average amount of reflux for the CFV was a median of 3.0 seconds with an interquartile range of 2.0 to 4.0 seconds. The average amount of reflux for the GSV was a median of 4.0 seconds with an interquartile range of 3.0 to 4.0 seconds. Postintervention VCSS (3.6 6 1.1) was significantly lower than preintervention VCSS (7.7 6 0.5; P < .001). Preintervention VCSS was lower than postintervention VCSS for both groups, but there was no significant difference between those who were treated with iliocaval stenting alone and those who had additional GSV ablation (3.6 6 1.1 seconds from 7.8 6 0.4 seconds and 3.7 6 1.3 seconds from 7.6 6 0.5 seconds [P ¼ .769], respectively; Fig) .
Conclusions: Iliocaval segment interrogation and intervention alone may be sufficient to treat patients with combined significant reflux of both CFV and GSV. Evaluation of possible underdiagnosed iliocaval disease is recommended before intervention is pursued for leg superficial venous reflux disease. Objective: Hybrid operative thrombectomy (HOT) is a novel technique that is noninferior to percutaneous techniques (PTs) for the treatment of iliofemoral deep venous thrombosis (IFDVT). Inferior vena cava (IVC) involvement is relatively uncommon and increases thrombus burden, which may affect outcomes. In this study, we compare HOT and PT in the setting of IFDVT with IVC involvement.
Methods: Since 2009 at our institution, 85 patients have undergone thrombus removal for acute symptomatic IFDVT. Of these, a minority had IVC involvement and were treated with HOT (n ¼ 4) or PT (n ¼ 5). HOT uses a single femoral venotomy for distal and proximal thrombectomy and avoids thrombolytics. PT included catheterdirected thrombolysis with or without pharmacomechanical thrombectomy. The primary end points were to compare perioperative and intermediate outcomes between the IVC treatment groups and to compare outcomes with patients who did not have IVC involvement (n ¼ 76).
Results: Nine patients had IVC involvement with extension to either single (n ¼ 6) or bilateral (n ¼ 3) iliofemoral segments. Mean onset of symptoms was 14 days for patients who underwent HOT and 10.6 days for PT. HOT trended toward establishing complete thrombus resolution (95%) more frequently than PT (75% vs 20%; P ¼ .09). There was a trend toward less postoperative drop in hemoglobin level in patients treated with HOT (10% vs 25%; P ¼ .08). Villalta scores and femoral-popliteal reflux times were similar regardless of technique at 2-year follow-up. However, Clinical, Etiology, Anatomy, and Pathophysiology classification and Villalta scores were significantly lower in patients without IVC involvement (P ¼ .02). Femoral-popliteal reflux times were <1 second in most patients regardless of IVC involvement.
Conclusions: HOT has several advantages, which include significant thrombus resolution in a single trip to the operating room, thrombolytics and associated complications are obviated, and similar intermediate outcomes. IVC involvement is associated with higher intermediate-term Villalta scores (suggestive of progression to post-thrombotic syndrome) compared with patients with isolated IFDVT.
Author Disclosures: A. Aboukheir-Aboukheir: Nothing to disclose; R. Figueroa-Vicenty: Nothing to disclose; J. L. Martinez-Trabal: Nothing to disclose; G. Pereira: Nothing to disclose; L. E. Rodriguez: Nothing to disclose; O. Rodriguez-Perez: Nothing to disclose; J. Sanchez-Vivaldi: Nothing to disclose. Objective: Submassive and massive pulmonary embolism (PE) is associated with high mortality, and effective treatment lies within a short window of time. In these instances, rapid diagnosis and treatment are vital for providing fast and efficacious care. We report a novel technique of intraoperative cone beam computed tomography pulmonary angiography (CBCT-PA) for diagnosis and treatment of PE in selected highly morbid cases.
Methods: Between April 2015 and February 2016, patients who underwent intraoperative CBCT-PA were retrospectively reviewed. In our hybrid operating room equipped with a robotic angiography system (Artis zeego; Siemens Healthcare GmbH, Erlangen, Germany), CBCT-PA images were acquired using a 5-second CBCT protocol (syngo DynaCT; Siemens) after injection of 40 mL of 50% iodinated contrast material at 8 mL/s through a pigtail catheter in the main pulmonary artery.
Results: Four patients underwent intraoperative CBCT-PA during the study period. Two of four patients (50%) were hemodynamically unstable in the intensive care unit and deemed unstable for transfer to computed tomography imaging in the radiology suite. These patients were taken directly to the operating room under high suspicion of massive PE and for possible intervention. In one patient, CBCT-PA revealed a large embolus in the left pulmonary artery (Fig 1) , prompting an attempt at mechanical thrombectomy. In the other patient, CBCT demonstrated only a small subsegmental embolus in the right lower lobe pulmonary artery (Fig 2) , which made PE the unlikely cause for acute decompensation. In the remaining two patients, CBCT imaging was performed for follow-up after placement of thrombolytic catheters the day before. CBCT demonstrated residual clot in subsegmental branches, and thrombolytic catheters were repositioned. Both patients did well after removal of thrombolytic catheters and prescription of systemic anticoagulation.
Conclusions: CBCT-PA is an effective adjunct imaging tool for diagnosis of PE in the operating room, especially in hemodynamically unstable patients, for whom transfer to the radiology imaging suite is often unsafe, and during catheter-directed thrombolysis. Until conventional computed tomography imaging becomes routinely available in the operating room, such novel intraoperative imaging options can be a valuable addition to the PE response team algorithm to optimize care in patients with PE. 
